# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Cerebral sarcoma

Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 1-10 of 24 results.
Children and Adolescents With Leukemia, Brain Tumors, and Sarcomas
Status: Not yet recruiting
Last Changed: Sep 26, 2019
First Received: Sep 24, 2019
Disease(s): Leukemia, Brain Tumor, Sarcoma, Childhood Cancer, Cancer, Adolescent Cancer
Intervention(s): Non-Interventional
Dose Escalation Study of CLR 131 in Children and Adolescents With Relapsed or Refractory Malignant Tumors Including But Not Limited to Neuroblastoma, Rhabdomyosarcoma, Ewings Sarcoma, and Osteosarcoma
Status: Recruiting
Last Changed: Dec 04, 2019
First Received: Mar 27, 2018
Disease(s): Pediatric Solid Tumor, Pediatric Lymphoma, Pediatric Brain Tumor, DIPG, Neuroblastoma, Ewing Sarcoma, Rhabdomyosarcoma, Osteosarcoma
Intervention(s): CLR 131
Locations: Texas Children's Hospital, Houston, Texas, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Refractory, Recurrent, or Advanced CNS or Leptomeningeal Cancer
Status: Recruiting
Last Changed: Apr 17, 2018
First Received: Aug 05, 2004
Disease(s): Brain and Central Nervous System Tumors, Neuroblastoma, Sarcoma
Intervention(s): iodine I 131 monoclonal antibody 8H9
Locations: Memorial Sloan Kettering Cancer Center, New York, New York, United States
Feasibility and Preliminary Efficacy of a Mindfulness-based Intervention for Children and Young Adults With High Grade or High-Risk Cancer and Their Caregivers
Status: Recruiting
Last Changed: Nov 22, 2019
First Received: May 28, 2018
Disease(s): Glioblastomas, Sarcoma, Astrocytoma, Brain Cancer, Leukemia
Intervention(s): Enhanced Mindfulness Intervention, Psychoeducation
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Sunitinib in Sarcomas of the Central Nervous System
Status: Recruiting
Last Changed: Dec 11, 2019
First Received: Aug 22, 2018
Disease(s): Gliosarcoma, Central Nervous System Sarcoma
Intervention(s): Sunitinib, wGT3x-BT
Locations: National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Abemaciclib in Children With DIPG or Recurrent/Refractory Solid Tumors
Status: Recruiting
Last Changed: Sep 04, 2019
First Received: Dec 31, 2015
Disease(s): Diffuse Intrinsic Pontine Glioma, Brain Tumor, Recurrent, Solid Tumor, Recurrent, Neuroblastoma, Recurrent, Refractory, Ewing Sarcoma, Recurrent, Refractory, Rhabdomyosarcoma, Recurrent, Refractory, Osteosarcoma, Recurrent, Refractory, Rhabdoid Tumor, Recurrent, Refractory
Intervention(s): Abemaciclib
Locations: Phoenix Children's Hospital, Phoenix, Arizona, United States
Children's Hospital Colorado, Aurora, Colorado, United States
Children's Healthcare of Atlanta, Egleston, Atlanta, Georgia, United States
Children's Healthcare of Atlanta, Scottish Rite, Atlanta, Georgia, United States
Methionine PET/CT Studies In Patients With Cancer
Status: Recruiting
Last Changed: Jun 18, 2019
First Received: Feb 10, 2009
Disease(s): Brain Tumors and/or Solid Tumors Including, Brain Stem Glioma, High Grade CNS Tumors, Ependymoma, Medulloblastoma, Craniopharyngioma, Low Grade CNS Tumors, Hodgkin Lymphoma, Non Hodgkin Lymphoma, Ewing Sarcoma, Osteosarcoma, Rhabdomyosarcoma, Neuroblastoma, Other
Intervention(s): Methionine
Locations: St. Jude Children's Research Hospital, Memphis, Tennessee, United States
The Master Registry of Oncology Outcomes Associated With Testing and Treatment
Status: Not yet recruiting
Last Changed: Sep 20, 2019
First Received: Jul 22, 2019
Disease(s): Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer, Appendix Cancer, Brain Tumor, Glioblastoma, Astrocytoma, Bile Duct Cancer, Cholangiocarcinoma, Bladder Cancer, Bone Cancer, Synovial Sarcoma, Chondrosarcoma, Liposarcoma, Sarcoma, Kaposi, Sarcoma,Soft Tissue, Sarcoma, Osteosarcoma, CNS Cancer, Brain Stem Neoplasms, Breast Cancer, Cervical Cancer, Colorectal Cancer, Rectal Cancer, Colon Cancer, Esophageal Cancer, Esophagus Cancer, Cancer of Colon, Pancreatic Cancer, Cancer of Pancreas, Testis Cancer, Testicular Cancer, Ureter Cancer, Renal Cell Carcinoma, Kidney Cancer, Gestational Trophoblastic Tumor, Head and Neck Neoplasms, Parotid Tumor, Larynx Cancer, Tongue Cancer, Pharynx Cancer, Salivary Gland Cancer, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Acute Lymphoblastic Leukemia, Multiple Myeloma, Non Hodgkin Lymphoma, Carcinoid Tumor, Lung Cancer, Neuroendocrine Tumors, Mesothelioma, Thyroid Cancer, Parathyroid Neoplasms, Adrenal Cancer, Small Bowel Cancer, Stomach Cancer, Liver Cancer, Hepatic Cancer, Melanoma, Skin Cancer, Unknown Primary Tumors, Uterine Cancer, Fallopian Tube Cancer, Ovarian Cancer, Prostate Cancer, Vaginal Cancer, Penile Cancer, Vulvar Cancer, Waldenstrom Macroglobulinemia, Cancer, Advanced, Thymus Cancer, Nasopharyngeal Carcinoma, Multiple Endocrine Neoplasia, Pheochromocytoma, Small Cell Carcinoma, Pulmonary Carcinoma
Intervention(s): Testing: Genome, Testing: Transcriptome, Testing: Proteome, Treatment: CAR-T
Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)
Status: Recruiting
Last Changed: Nov 20, 2019
First Received: Oct 05, 2015
Disease(s): Breast Cancer, Cholangiocarcinoma, Colorectal Cancer, Head and Neck Neoplasms, Lymphoma, Large-Cell, Anaplastic, Melanoma, Neuroendocrine Tumors, Non-Small Cell Lung Cancer, Ovarian Cancer, Pancreatic Cancer, Papillary Thyroid Cancer, Primary Brain Tumors, Renal Cell Carcinoma, Sarcomas, Salivary Gland Cancers, Adult Solid Tumor
Intervention(s): Entrectinib
Locations: Western Regional Medical Center at Cancer Treatment Centers of America, Goodyear, Arizona, United States
Dignity Health St Joseph's Hospital and Medical Center, Phoenix, Arizona, United States
Mayo Clinic, Scottsdale, Arizona, United States
City of Hope Cancer Center; Division of Medical Oncology & Experimental Therapeutics, Duarte, California, United States
Scripps Clinic, La Jolla, California, United States
... and 141 other locations.
StrataXRT in Preventing Radiation Dermatitis in Pediatric Patients Undergoing Radiation Therapy to the Brain or Spinal Cord
Status: Not yet recruiting
Last Changed: Jun 19, 2019
First Received: Jun 19, 2019
Disease(s): Central Nervous System Sarcoma, Ependymoma, Glioma, Malignant Intracranial Germ Cell Tumor, Medulloblastoma, Pineoblastoma, Primary Central Nervous System Neoplasm
Intervention(s): Placebo, Questionnaire Administration, Wound Dressing Material
Locations: M D Anderson Cancer Center, Houston, Texas, United States